OR WAIT null SECS
June 19, 2018
The acquisition and integration of Cook Pharmica LLC’s business and facility into Catalent’s global biologics network facilities allow its clients to benefit from end-to-end solutions in biologic drug development.
April 10, 2018
February 28, 2018
Catalent partners with innovators to accelerate programmes through the early phases of development, overcome a molecule’s solubility and bioavailability challenges, and increase its likelihood of success in the clinic.
December 06, 2017
September 01, 2017
August 15, 2017
Catalent has the broadest range of technologies and solutions to overcome developmental and bioavailability challenges, and to enhance product performance.